High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key.
作者信息
Terlizzi Mario, Bossi Alberto
机构信息
Radiation Therapy Department and Brachytherapy Unit, Institut Gustave Roussy, Villejuif, France.
出版信息
Eur Urol Open Sci. 2022 Feb 10;38:14-16. doi: 10.1016/j.euros.2021.07.010. eCollection 2022 Apr.
Abstract
摘要
相似文献
1
High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key.高危局部晚期前列腺癌：多模式治疗是关键。
Eur Urol Open Sci. 2022 Feb 10;38:14-16. doi: 10.1016/j.euros.2021.07.010. eCollection 2022 Apr.
2
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.高风险局限性和局部进展性前列腺癌的主要治疗方法的获益与风险：一项国际多学科系统评价。
Eur Urol. 2020 May;77(5):614-627. doi: 10.1016/j.eururo.2020.01.033. Epub 2020 Mar 4.
3
Role of robot-assisted radical prostatectomy in locally advanced prostate cancer.机器人辅助根治性前列腺切除术在局部晚期前列腺癌中的作用。
Int J Urol. 2018 Jan;25(1):30-35. doi: 10.1111/iju.13441. Epub 2017 Sep 13.
4
Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy.前列腺癌根治术和扩大淋巴结清扫术后高危局部晚期前列腺癌的多模式治疗。
Minerva Urol Nefrol. 2019 Oct;71(5):508-515. doi: 10.23736/S0393-2249.19.03388-5. Epub 2019 Apr 5.
5
The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer.雄激素剥夺疗法在局限性和局部晚期前列腺癌治疗中的现代作用。
J Clin Urol. 2016 Dec;9(2 Suppl):24-29. doi: 10.1177/2051415816654048. Epub 2016 Dec 1.
6
Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer.机器人辅助前列腺切除术治疗局部晚期和转移性前列腺癌的当代疗效
Transl Androl Urol. 2021 May;10(5):2178-2187. doi: 10.21037/tau-20-1002.
7
Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.机器人辅助根治性前列腺切除术和扩展盆腔淋巴结清扫术治疗局部进展期前列腺癌。
Eur Urol. 2017 Feb;71(2):249-256. doi: 10.1016/j.eururo.2016.05.008. Epub 2016 May 18.
8
Treatment of locally advanced prostate cancer: is chemotherapy the next step?局部晚期前列腺癌的治疗：化疗是下一步的选择吗？
J Clin Oncol. 1999 Nov;17(11):3664-75. doi: 10.1200/JCO.1999.17.11.3664.
9
Pretreatment tables predicting pathologic stage of locally advanced prostate cancer.预测局部晚期前列腺癌病理分期的预处理表。
Eur Urol. 2015 Feb;67(2):319-25. doi: 10.1016/j.eururo.2014.03.013. Epub 2014 Mar 21.
10
Extended followup oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b).局部进展期前列腺癌（T2c-T3b）冷冻消融与外照射放疗随机对照临床试验的长期肿瘤学随访结果。
J Urol. 2012 Oct;188(4):1170-5. doi: 10.1016/j.juro.2012.06.014. Epub 2012 Aug 15.
引用本文的文献
1
Prostate Cancer With Orbital Metastasis.前列腺癌伴眼眶转移
Cureus. 2025 Mar 17;17(3):e80727. doi: 10.7759/cureus.80727. eCollection 2025 Mar.
2
Poly I:C-priming of adipose-derived mesenchymal stromal cells promotes a pro-tumorigenic phenotype in an immunocompetent mouse model of prostate cancer.聚肌胞苷酸预处理脂肪来源的间充质基质细胞在免疫健全的前列腺癌小鼠模型中促进促肿瘤表型。
Front Cell Dev Biol. 2023 Nov 22;11:1145421. doi: 10.3389/fcell.2023.1145421. eCollection 2023.
本文引用的文献
1
The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis.根治性前列腺切除术和放疗治疗高危前列腺癌的疗效和安全性：系统评价和荟萃分析。
World J Surg Oncol. 2020 Feb 24;18(1):42. doi: 10.1186/s12957-020-01824-9.
2
Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality.手术与放疗在处理活检前列腺癌评分 9-10 级及死亡率风险中的比较。
JAMA Oncol. 2019 Feb 1;5(2):213-220. doi: 10.1001/jamaoncol.2018.4836.
3
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.根治性前列腺切除术、外照射放疗、外照射放疗联合近距离放疗增敏与 Gleason 评分 9 - 10 前列腺癌患者的疾病进展及死亡率
JAMA. 2018 Mar 6;319(9):896-905. doi: 10.1001/jama.2018.0587.
4
Natural history of surgically treated high-risk prostate cancer.手术治疗高危前列腺癌的自然病史。
Urol Oncol. 2015 Apr;33(4):163.e7-13. doi: 10.1016/j.urolonc.2014.11.018. Epub 2015 Feb 7.
5
Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.前列腺癌手术、放疗或两者联合治疗后的尿不良事件长期倾向性风险。
Eur Urol. 2015 Feb;67(2):273-80. doi: 10.1016/j.eururo.2014.08.061. Epub 2014 Sep 10.
6
High-risk prostate cancer-classification and therapy.高危前列腺癌——分类与治疗
Nat Rev Clin Oncol. 2014 Jun;11(6):308-23. doi: 10.1038/nrclinonc.2014.68. Epub 2014 May 20.
7
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.临床局限性前列腺癌患者根治性前列腺切除术或外照射放疗后的转移：基于病例组合调整的临床队列比较。
J Clin Oncol. 2010 Mar 20;28(9):1508-13. doi: 10.1200/JCO.2009.22.2265. Epub 2010 Feb 16.
8
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.预测前列腺癌根治术后复发性前列腺癌挽救性放射治疗的结果。
J Clin Oncol. 2007 May 20;25(15):2035-41. doi: 10.1200/JCO.2006.08.9607.
9
Prostate cancer progression after therapy of primary curative intent: a review of data from prostate-specific antigen era.
Cancer. 2005 Dec 1;104(11):2310-22. doi: 10.1002/cncr.21441.
10
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.局部晚期前列腺癌患者立即进行雄激素抑制和外照射的长期结果（一项欧洲癌症研究与治疗组织的研究）：一项III期随机试验
Lancet. 2002 Jul 13;360(9327):103-6. doi: 10.1016/s0140-6736(02)09408-4.
Zotero 插件